Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignanciesJosé María Sánchez‐Pina, María Calbacho, Rodrigo Íñiguez et al.|European Journal Of Haematology|2020Cited by 96
Impact of COVID-19 in patients with multiple myeloma based on a global data networkJoaquín Martínez‐López, Gema Hernández, R. Alonso et al.|Blood Cancer Journal|2021Cited by 59
Impact of IPSS-M implementation in real-life clinical practiceIrene Zamanillo, María‐Teresa Cedena, María Poza et al.|Frontiers in Oncology|2023Cited by 8
Exploratory Study to Evaluate the Impact of Interim PET/CT Assessment in First-Line Follicular LymphomaMaría Poza, Ana Jiménez Ubieto, Alejandro Martín-Muñoz et al.|Cancers|2025Cited by 4
Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab FailureIrene Zamanillo, Joaquín Martínez‐López, Lucia Medina de Alba et al.|Life|2023Cited by 2